Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancer

Journal of Steroid Biochemistry and Molecular Biology

Volumn 148, Issue , 2015, Pages 148-155

  Wahler, Joseph ^a   So, Jae Young ^a   Cheng, Larry C ^a   Maehr, Hubert ^a   Uskokovic, Milan ^a   Suh, Nanjoo ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

Breast cancer; Mammosphere; Stem cell; Vitamin D; Vitamin D analog

Indexed keywords

1ALPHA,25 DIHYDROXY 21 (3 HYDROXY 3 DEUTEROMETHYL 4,4,4 TRIDEUTEROBUTYL) 23 YNE 26,27 HEXAFLUOROCHOLECALCIFEROL; ALPHA6 INTEGRIN; ANTIMITOTIC AGENT; ANTINEOPLASTIC AGENT; CALCITRIOL; CALCITRIOL DERIVATIVE; CD24 ANTIGEN; CYCLINE; HERMES ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KRUPPEL LIKE FACTOR 4; NOTCH1 RECEPTOR; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; MESSENGER RNA; TUMOR MARKER; VITAMIN; VITAMIN D;

ANTIPROLIFERATIVE ACTIVITY; BREAST CANCER; BREAST CANCER CELL LINE; BREAST CANCER STEM CELL; BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST CELL; BREAST EPITHELIUM CELL; CANCER CELL CULTURE; CANCER STEM CELL; CELL RENEWAL; CELL SHAPE; CONFERENCE PAPER; CONTROLLED STUDY; GENE REPRESSION; HUMAN; HUMAN CELL; INTRADUCTAL CARCINOMA; MCF10A CELL LINE; MITOSIS INHIBITION; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; STEM CELL RESEARCH; APOPTOSIS; BREAST; BREAST NEOPLASMS; CELL PROLIFERATION; DRUG EFFECTS; FEMALE; FLOW CYTOMETRY; GENETICS; METABOLISM; MULTICELLULAR SPHEROID; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; WESTERN BLOTTING;

APOPTOSIS; BIOMARKERS, TUMOR; BLOTTING, WESTERN; BREAST; BREAST NEOPLASMS; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; HUMANS; NEOPLASTIC STEM CELLS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED; VITAMIN D; VITAMINS;

EID: 84925467484     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2014.10.016     Document Type: Conference Paper

References (46)

1. L.A. Brinton, M.E. Sherman, J.D. Carreon, and W.F. Anderson Recent trends in breast cancer among younger women in the United States J. Natl. Cancer Inst. 100 2008 1643 1648
2. B. Fowble, A.L. Hanlon, D.A. Fein, J.P. Hoffman, E.R. Sigurdson, and A. Patchefsky Results of conservative surgery and radiation for mammographically detected ductal carcinoma in situ (DCIS) Int. J. Radiat. Oncol. Biol. Phys. 38 1997 949 957
3. L.C. Collins, R.M. Tamimi, H.J. Baer, J.L. Connolly, G.A. Colditz, and S.J. Schnitt Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study Cancer 103 2005 1778 7784
4. M.E. Sanders, P.A. Schuyler, W.D. Dupont, and D.L. Page The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up Cancer 103 2005 2481 2484
5. S.A. Mani, W. Guo, M.J. Liao, E.N. Eaton, A. Ayyanan, and A.Y. Zhou The epithelial-mesenchymal transition generates cells with properties of stem cells Cell 133 2008 704 715
6. M. Al-Hajj, M.S. Wicha, A. Benito-Hernandez, S.J. Morrison, and M.F. Clarke Prospective identification of tumorigenic breast cancer cells Proc. Natl. Acad. Sci. U. S. A 100 2003 3983 3988
7. M.S. Wicha Targeting self-renewal an Achilles' heel of cancer stem cells Nat. Med. 20 2014 14 15
8. S. Gangopadhyay, A. Nandy, P. Hor, and A. Mukhopadhyay Breast cancer stem cells: a novel therapeutic target Clin. Breast Cancer 13 2013 7 15
9. M.P. Ablett, J.K. Singh, and R.B. Clarke Stem cells in breast tumours: are they ready for the clinic Eur. J. Cancer 48 2012 2104 2116
10. X. Li, M.T. Lewis, J. Huang, C. Gutierrez, C.K. Osborne, and M.F. Wu Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy J. Natl. Cancer Inst. 100 2008 672 679
11. F. Yu, H. Yao, P. Zhu, X. Zhang, Q. Pan, and C. Gong let-7 regulates self renewal and tumorigenicity of breast cancer cells Cell 131 2007 1109 1123
12. H. Korkaya, S. Liu, and M.S. Wicha Breast cancer stem cells, cytokine networks, and the tumor microenvironment J. Clin. Invest. 121 2011 3804 3809
13. J.E. Visvader, and G.J. Lindeman Cancer stem cells in solid tumours: accumulating evidence and unresolved questions Nat. Rev. Cancer 8 2008 755 758
14. F. Vaillant, M.L. Asselin-Labat, M. Shackleton, G.J. Lindeman, and J.E. Visvader The emerging picture of the mouse mammary stem cell Stem Cell Rev. 3 2007 114 123
15. H.G. Palmer, J.M. Gonzalez-Sancho, J. Espada, M.T. Berciano, I. Puig, and J. Baulida Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling J. Cell Biol. 154 2001 369 387
16. S.L. Maund, W.W. Barclay, L.D. Hover, L.S. Axanova, G. Sui, and J.D. Hipp Interleukin-1alpha mediates the antiproliferative effects of 1,25-dihydroxyvitamin D3 in prostate progenitor/stem cells Cancer Res. 71 2011 5276 5286
17. J.Y. So, H.J. Lee, A.K. Smolarek, S. Paul, C.X. Wang, and H. Maehr A novel Gemini vitamin D analog represses the expression of a stem cell marker CD44 in breast cancer Mol. Pharmacol. 79 2011 360 367
18. Q. Li, Y. Yao, G. Eades, Z. Liu, Y. Zhang, and Q. Zhou Downregulation of miR-140 promotes cancer stem cell formation in basal-like early stage breast cancer Oncogene 33 2014 2589 2600
19. J. Wahler, J.Y. So, Y.C. Kim, F. Liu, H. Maehr, and M. Uskokovic Inhibition of the transition of ductal carcinoma in situ to invasive ductal carcinoma by a Gemini vitamin D analog Cancer Prev. Res. (Phila). 7 2014 617 626
20. D. Feldman, A.V. Krishnan, S. Swami, E. Giovannucci, and B.J. Feldman The role of vitamin D in reducing cancer risk and progression Nat. Rev. Cancer 14 2014 342 357
21. D. Ponti, A. Costa, N. Zaffaroni, G. Pratesi, G. Petrangolini, and D. Coradini Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties Cancer Res. 65 2005 5506 5511
22. L.M. Rota, D.A. Lazzarino, A.N. Ziegler, D. LeRoith, and T.L. Wood Determining mammosphere-forming potential: application of the limiting dilution analysis J. Mammary Gland Biol. Neoplasia 17 2012 119 123
23. H. Maehr, H.J. Lee, B. Perry, N. Suh, and M.R. Uskokovic Calcitriol derivatives with two different side chains at C-20: V. Potent inhibitors of mammary carcinogenesis and inducers of leukemia differentiation J. Med. Chem. 52 2009 5505 5519
24. J.Y. So, J.J. Lin, J. Wahler, K.T. Liby, M.B. Sporn, and N. Suh A Synthetic Triterpenoid CDDO-Im inhibits tumorsphere formation by regulating stem cell signaling pathways in triple-negative breast cancer PLoS One 9 2014 e107616
25. H.J. Lee, J. Ju, S. Paul, J.Y. So, A. DeCastro, and A. Smolarek Mixed tocopherols prevent mammary tumorigenesis by inhibiting estrogen action and activating PPAR-gamma Clin. Cancer Res. 15 2009 4242 4249
26. H.J. Lee, H. Liu, C. Goodman, Y. Ji, H. Maehr, and M. Uskokovic Gene expression profiling changes induced by a novel Gemini Vitamin D derivative during the progression of breast cancer Biochem. Pharmacol. 72 2006 332 343
27. J.Y. So, A.K. Smolarek, D.M. Salerno, H. Maehr, M. Uskokovic, and F. Liu Targeting CD44-STAT3 signaling by Gemini vitamin D analog leads to inhibition of invasion in basal-like breast cancer PloS One 8 2013 e54020
28. E.A. Rakha, J.S. Reis-Filho, and I.O. Ellis Basal-like breast cancer: a critical review J. Clin. Oncol. 26 2008 2568 2581
29. R.L. Atkinson, W.T. Yang, D.G. Rosen, M.D. Landis, H. Wong, and M.T. Lewis Cancer stem cell markers are enriched in normal tissue adjacent to triple negative breast cancer and inversely correlated with DNA repair deficiency Breast Cancer Res. 15 2013 R77
30. M.J. Meyer, J.M. Fleming, A.F. Lin, S.A. Hussnain, E. Ginsburg, and B.K. Vonderhaar CD44posCD49fhiCD133/2hi defines xenograft-initiating cells in estrogen receptor-negative breast cancer Cancer Res. 70 2010 4624 4633
31. J. Stingl, C.J. Eaves, I. Zandieh, and J.T. Emerman Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue Breast Cancer Res. Treat. 67 2001 93 109
32. G. Dontu, W.M. Abdallah, J.M. Foley, K.W. Jackson, M.F. Clarke, and M.J. Kawamura In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells Genes Dev. 17 2003 1253 1270
33. C.M. Fillmore, and C. Kuperwasser Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy Breast Cancer Res. 10 2008 R25
34. G. Honeth, P.O. Bendahl, M. Ringner, L.H. Saal, S.K. Gruvberger-Saal, and K. Lovgren The CD44+/CD24- phenotype is enriched in basal-like breast tumors Breast Cancer Res. 10 2008 R53
35. S. Ricardo, A.F. Vieira, R. Gerhard, D. Leitao, R. Pinto, and J.F. Cameselle-Teijeiro Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype J. Clin. Pathol. 64 2011 937 946
36. J.A. de la Mare, J.N. Sterrenberg, M.G. Sukhthankar, M.T. Chiwakata, D.R. Beukes, and G.L. Blatch Assessment of potential anti-cancer stem cell activity of marine algal compounds using an in vitro mammosphere assay Cancer Cell Int. 13 2013 39
37. H. Ponta, L. Sherman, and P.A. Herrlich CD44: from adhesion molecules to signalling regulators Nat. Rev. Mol. Cell Biol. 4 2003 33 45
38. P.V. Pham, N.L. Phan, N.T. Nguyen, N.H. Truong, T.T. Duong, and D.V. Le Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy J. Transl. Med. 9 2011 209
39. M. Cariati, A. Naderi, J.P. Brown, M.J. Smalley, S.E. Pinder, and C. Caldas Alpha-6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF7 breast cancer cell line Int. J. Cancer 122 2008 298 304
40. G. Dontu, M. Al-Hajj, W.M. Abdallah, M.F. Clarke, and M.S. Wicha Stem cells in normal breast development and breast cancer Cell Prolif. 36 Suppl 1 2003 59 72
41. K. Shostak, and A. Chariot NF-kappaB, stem cells and breast cancer: the links get stronger Breast Cancer Res. 13 2011 214
42. M. Cioce, S. Gherardi, G. Viglietto, S. Strano, G. Blandino, and P. Muti Mammosphere-forming cells from breast cancer cell lines as a tool for the identification of CSC-like- and early progenitor-targeting drugs Cell Cycle 9 2010 2878 2887
43. M. Liu, T. Sakamaki, M.C. Casimiro, N.E. Willmarth, A.A. Quong, and X. Ju The canonical NF-kappaB pathway governs mammary tumorigenesis in transgenic mice and tumor stem cell expansion Cancer Res. 70 2010 10464 10473
44. H. Zaehres, M.W. Lensch, L. Daheron, S.A. Stewart, J. Itskovitz-Eldor, and G.Q. Daley High-efficiency interference in human embryonic stem cells Stem Cells 23 2005 299 305
45. D.J. Rodda, J.L. Chew, L.H. Lim, Y.H. Loh, B. Wang, and H.H. Ng Transcriptional regulation of nanog by OCT4 and SOX2 J. Biol. Chem. 280 2005 24731 24737
46. M.L. Asselin-Labat, K.D. Sutherland, H. Barker, R. Thomas, M. Shackleton, and N.C. Forrest Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation Nat. Cell Biol. 9 2007 201 209